Cargando…
Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?
The toll-like receptor (TLR) system constitutes a pylogenetically ancient, evolutionary conserved, archetypal pattern recognition system, which underpins pathogen recognition by and activation of the immune system. Toll-like receptor agonists have long been used as immunoadjuvants in anti cancer imm...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360630/ https://www.ncbi.nlm.nih.gov/pubmed/16892041 http://dx.doi.org/10.1038/sj.bjc.6603275 |